Arcadia Biosciences (RKDA) Cash & Current Investments (2014 - 2026)

Arcadia Biosciences (RKDA) has 12 years of Cash & Current Investments data on file, last reported at $4.6 million in Q4 2025.

• Quarterly Cash & Current Investments rose 8.53% year-over-year to $4.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.6 million (up 8.53% YoY) and the FY2025 annual result came in at $4.6 million, up 8.53% from the prior year.
• Cash & Current Investments eased to $4.6 million in Q4 2025, from $5.9 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $51.9 million in Q1 2021 to a low of $3.2 million in Q1 2025.
• A 5-year average of $18.2 million and a median of $17.1 million in 2023 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2021 — Cash & Current Investments surged 340.55% — and 2024, when it sank 63.56%.
• Tracing RKDA's Cash & Current Investments over 5 years: stood at $28.7 million in 2021, then dropped by 28.03% to $20.6 million in 2022, then plunged by 43.61% to $11.6 million in 2023, then slumped by 63.56% to $4.2 million in 2024, then grew by 8.53% to $4.6 million in 2025.
• The last three Cash & Current Investments figures came in at $4.6 million (Q4 2025), $5.9 million (Q3 2025), and $4.4 million (Q2 2025), per Business Quant data.